Pinnacle Financial Group, Inc.’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Other funds holding BMRN
Pinnacle Financial Group, Inc.'s BMRN Position: Q3 2026 in Review
Pinnacle Financial Group, Inc. opened a new position in BioMarin Pharmaceuticals (BMRN) in Q3 2026: 500 shares worth $30K. The stake represents ﹤0.01% of the portfolio and ranks #1175 among its holdings.
567 funds tracked by Wall St. Rank hold BMRN as of Q3 2026.
- Pinnacle Financial Group, Inc. held 500 shares of BioMarin Pharmaceuticals worth $30K as of Q3 2026.
- BioMarin Pharmaceuticals was a new Pinnacle Financial Group, Inc. position in Q3 2026.
- BioMarin Pharmaceuticals made up ﹤0.01% of Pinnacle Financial Group, Inc.'s portfolio in Q3 2026, its #1175 holding.
- 567 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2026.
Based on Pinnacle Financial Group, Inc.'s 13F filing for Q3 2026, filed 16 Nov 2026.